Market revenue in 2023 | USD 3.0 million |
Market revenue in 2030 | USD 5.0 million |
Growth rate | 7.4% (CAGR from 2023 to 2030) |
Largest segment | Inactivated (killed) |
Fastest growing segment | Other Vaccines |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Modified/ Attenuated Live, Inactivated (Killed), Other Vaccines |
Key market players worldwide | Zoetis, Phibro Animal Health Corp Class A, Elanco Animal Health Inc, Merck & Co Inc, Choong Ang Vaccine Laboratories (CAVAC), Kyoto Biken Laboratories, Nissenken, KBNP, Vaxxinova, HIPRA |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to aquaculture vaccines market will help companies and investors design strategic landscapes.
Inactivated (killed) was the largest segment with a revenue share of 36.67% in 2023. Horizon Databook has segmented the Argentina aquaculture vaccines market based on modified/ attenuated live, inactivated (killed), other vaccines covering the revenue growth of each sub-segment from 2018 to 2030.
According to OECD’s January 2021 report on Fisheries and Aquaculture in Argentina, the country’s fish production was valued at USD 2.83 billion in 2018. The country has also adopted UN’s 2030 Agenda for Sustainable Development to end overfishing and regulate fishing activities based on scientific research.
The country’s aquaculture potential lies in its 3,000 km long coastline and freshwater resources. To promote its aquaculture sector and the potential for increased fish production, the government approved a New Aquaculture Act in 2015.
The growing aquaculture industry presents opportunities for market players involved in aquaculture vaccines. For instance, in February 2021, an Argentinian startup— FeedVax, developed an oral vaccine against Streptococcus infection in tilapia for the South American market.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina aquaculture vaccines market , including forecasts for subscribers. This country databook contains high-level insights into Argentina aquaculture vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account